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MCostochondral Calcification, Osteophytic Degeneration, and Occult
First Rib Fractures in Patients With Venous Thoracic Outlet Syndrome
George Sheng, Valerie Emery, RN, Robert Thompson, MD, Vascular Sur-
gery, Washington University, Saint Louis, Mo
Objectives: Subclavian vein (SCV) compression in venous thoracic outlet
syndrome (TOS)has been attributed to various anatomic factors, but a potential
role for costochondral degeneration in the underlying first rib has not been
previously examined. The purpose of this studywas to examine the frequency of
costochondral calcification (CC), osteophytic degeneration (OD), and occult
first rib fracture (FRFx) in patients with venous TOS.
Methods: During a 12-month period 37 patients with SCV effort
thrombosis received surgical treatment of venous TOS. All patients under-
went paraclavicular thoracic outlet decompression with complete resection
of the first rib. The presence or absence of CC, OD and FRFx was deter-
mined by direct visual examination of the rib at operation and following
debridement of adherent soft tissues in the excised specimen.
Results:No patient has radiographic first rib abnormalities. FRFx were
observed in 16 of 37 patients (43%). All FRFx were small, nondisplaced,
linear lesions located within an area of CC in the anterior rib medial to the
scalene tubercle. The mean age of patients with FRFx was higher than those
with a normal first rib (38.1  1.5 yr vs 25.0  2.3 yr; P  0.0001), and
FRFx was present in 16 of 21 (76%) patients 30 years of age but in no
patients younger than 30 (P  0.0001).
Conclusions: A high proportion (43%) of patients with venous TOS
exhibited CC, OD, and a previously undetected FRFx, including 76% of
those over the age of 30. These lesions occur in the cartilaginous anterior rib
where they are clinically occult and undetected by standard radiographic
imaging.We postulate that age-related CCmay predispose to stress-induced
OD and FRFx, and that inflammation and anatomic distortion may contribute
to SCV compression. Further investigation will be needed to determine the
cause(s) and influence of occult FRFx in the development of venous TOS.
Adjunctive Use of the Superficial Femoral Vein for Vascular
Reconstructions
Soma Brahmanandam, MD, Daniel Clair, MD, James Bena, Timur Sarac,
MD, Cleveland Clinic Foundation, Cleveland, Ohio
Objectives: While the superficial femoral vein (SFV) is an accepted
treatment for aortic graft infections, this conduit also has potential uses in
other areas.We evaluate our experience using the SFV for arterial and venous
bypasses, and arteriovenous (AV) fistula for dialysis access.
Methods: Between 1999-2011, 42 patients underwent a bypass or a
thigh AV fistula using the SFV (31 arterial, 4 central venous, 6 AV fistula,
and 1 common carotid-to-vertebral bypass). Indications for arterial bypass
included: infected graft (20), critical limb ischemia (9), and failed previous
bypass (4). Indications for central venous bypass were: SVC syndrome (2);
vessel reconstruction due to tumor encasement (1); and central vein occlu-
sion from thoracic outlet syndrome (1). All AV fistulas were created after
patients suffered bilateral subclavian vein occlusions from failed upper ex-
tremity access. The common carotid-to-vertebral bypass was created due to
an occluded vertebral artery with resultant stroke.
Results: Kaplan Meier cumulative patency curves are shown in the Fig.
The primary patency rates at 30 days, 1 and 3 years were 97.4% (95% CI,
92.41,100), 74.6% (95% CI, 57.89,96.23) and 66.4% (95% CI, 47.06,93.53),
respectively. The assisted primary patency rates at 30 days, 1, and 3 years were
100% (95% CI, 100,100), 97.1% (95% CI, 91.54,100) and 89% (95% CI,
74.29,100), respectively. Secondary patency rates at 30 days, 1, and3 yearswere
100% (95% CI, 100,100), 97.1% (95% CI, 91.54,100) and 89% (95% CI,
74.29,100), respectively. Limb salvage rates at 30 days, 1, and 3 years were
97.3% (95% CI, 92.21,100), 89.3% (95% CI, 78.35,100), and 89.3% (95% CI,
78.35,100), respectively. Survival rates at 30 days, 1, and 3 years were 97.6%
(95%CI, 92.95,100), 86% (95%CI, 75.3,98.3), and 86% (95%CI, 75.3,98.3),
respectively. Follow-up ranged from 1 month to 8.7 years (mean time, 21
months). Complications occurred in 22 patients (52%) and included: wound
complications (n  19, 45.2%); deep vein thrombosis (n  1, 2.4%); anasto-
motic breakdown (n  1, 2.4%); hematoma (n  5, 11.9%); pulmonary
embolism (n 2, 4.8%); and compartment syndrome (n 2, 4.8%).
Conclusions: The SFV is a durable conduit for uses beyond aortic
reconstruction and should be considered when the GSV is not available, or
size match is a concern. However, wound complications remain a problem. a
1540ndovascular Repair of Abdominal Aortic Aneurysm Does Not Im-
rove Survival versus Open Repair in Patients Sixty Years or Younger
rateek K.Gupta, BalaNatarajan,MD, Xiang Fang, PhD,Marcus Balters,MD,
ason M. Johanning, MD, Thomas G. Lynch, MD, Gernon M. Longo, MD,
asonN.MacTaggart,MD, Iraklis I. Pipinos,MD, Surgery, CreightonUniver-
ity, Omaha, Neb
Objectives:Multiple randomized trials have demonstrated lower post-
perative morbidity and mortality after endovascular repair (EVAR) com-
ared to open repair (OAR) for infrarenal abdominal aortic aneurysms
AAA). This advantage for EVAR has, however, been mostly in relatively
lder patients with no study specifically comparing EVAR and OAR for
atients 60 years or younger.
Methods:We compared the 30-day mortality outcomes of EVAR and
AR for elective infrarenal AAA repair in patients 60 years of age or younger
ho were identified from the 2007-09 National Surgical Quality Improve-
ent Program - a multicenter (more than 180 hospitals), prospective
atabase. The 30-day mortality rate from the NSQIP analysis was then
ombined with the 30-day to 2-year aneurysm-related mortality rate after
AA repair from the OVER trial (0.9% for EVAR and 0% for OAR) to
etermine the 2-year aneurysm-related mortality rate for EVAR and OAR.
Results: Of the 651 patients, 369 (56.7%) underwent EVAR and 282
43.3%) underwent OAR. Patients undergoing EVAR were more commonly
ales (90.8% vs 80.5%; P .0002) and dialysis dependent (3.0% vs. 0.4%; P
01). There were no differences between the two groups in terms of diabetes,
unctional status, COPD, heart failure, myocardial infarction, peripheral arterial
isease, andASA class (P .05). Thirty-daymortality for EVAR andOARwere
.1% and 0.4%, respectively (P  .22). If the 30-day mortality rate from our
SQIP analysis is combined with the 30-day to 2-year aneurysm-related mor-
ality rate after AAA repair from the OVER trial, the 2-year aneurysm-related
ortality rate for EVAR and OAR are 2% and 0.4%, respectively.
Conclusions: The two-year peri-procedural and aneurysm-related
ortality rate after OAR is similar to, if not lower than EVAR in patients 60
ears or younger with infrarenal AAA. This calls for a randomized prospec-
ive trial comparing OAR and EVAR in these patients.
stimating the Risk of Radiation Associated Malignancy in Patients
ndergoing Routine Computed Tomography for Surveillance of Aor-
ic Endografts Using BEIR VII Model: Is It Time to Redefine the
ollow-up Protocol
aghu L. Motaganahalli, Angela Qualey Martin, MD, BeeJay Feliciano,
D, Gary W. Lemmon, MD, Alan P. Sawchuk, MD, Michael P. Murphy,
D, Andres Fajardo, MD, George Akingba, MD, Dolores Cikrit, MD,
ichael C. Dalsing, MD, Vascular Surgery, Indiana University School of
edicine, Indianapolis, Ind
Fig.Objectives: Patients undergoing endovascular repair of abdominal
ortic aneurysms (EVAR) are routinely subjected to CTAngiography (CTA)
